These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7824484)

  • 21. [Efficient ambulatory and post-discharge thromboprophylaxis with fully automated pens].
    Höntzsch D; Scheffer J; Hafner S
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1060-2. PubMed ID: 9574332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis.
    Riess H; Koppenhagen K; Tolle A; Kemkes-Matthes B; Gräve M; Patek F; Drexler M; Siemens HJ; Harenberg J; Weidinger G; Brom J; Haas S;
    Thromb Haemost; 2003 Aug; 90(2):252-9. PubMed ID: 12888872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemorrhage complicating heparin treatment in a patient with myxedema].
    Bulckaen E; Woestelandt H; Le Borgne JM; Chanteau C
    Ann Fr Anesth Reanim; 1996; 15(2):202-3. PubMed ID: 8734243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Body weight adapted anticoagulation is passé. Thrombosis therapy without scales].
    MMW Fortschr Med; 2003 Dec; 145(50):59. PubMed ID: 14963979
    [No Abstract]   [Full Text] [Related]  

  • 25. Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial.
    Lopaciuk S; Meissner AJ; Filipecki S; Zawilska K; Sowier J; Ciesielski L; Bielawiec M; Glowinski S; Czestochowska E
    Thromb Haemost; 1992 Jul; 68(1):14-8. PubMed ID: 1325076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Summaries for Patients. Low-Molecular-Weight Heparin for Women With Unexplained Recurrent Pregnancy Loss.
    Ann Intern Med; 2015 May; 162(9):I-22. PubMed ID: 26146666
    [No Abstract]   [Full Text] [Related]  

  • 27. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe hemorrhage after low-molecular-weight heparin treatment in a preterm neonate.
    van Elteren HA; Te Pas AB; Kollen WJ; Walther FJ; Lopriore E
    Neonatology; 2011; 99(4):247-9. PubMed ID: 21063129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed hypersensitivity challenged by subcutaneous Bemiparin.
    Moreno Escobosa MC; Moya Quesada MC; Granados SC; Amat López J
    Allergol Immunopathol (Madr); 2011; 39(5):309-10. PubMed ID: 21129837
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of venous thromboembolism with low-molecular-weight heparins].
    Haas S; Haas P; Creutzig A
    Vasa; 2000 Feb; 29(1):5-10. PubMed ID: 10731882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
    Hull R; Raskob G; Pineo G; Rosenbloom D; Evans W; Mallory T; Anquist K; Smith F; Hughes G; Green D
    N Engl J Med; 1993 Nov; 329(19):1370-6. PubMed ID: 8413432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
    Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
    Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy.
    Thomson AJ; Walker ID; Greer IA
    Lancet; 1998 Dec; 352(9144):1904. PubMed ID: 9863791
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapy of thromboses with low molecular weight heparins].
    Haas S
    Z Kardiol; 1993; 82 Suppl 2():77-80. PubMed ID: 8392238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteers.
    Harenberg J; Giese C; Dempfle CE; Stehle G; Heene DL
    Thromb Haemost; 1989 Jun; 61(3):357-62. PubMed ID: 2552604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance of intravenous low-molecular-weight heparin after eczematous reaction to subcutaneous heparin.
    Koch P; Bahmer FA; Schäfer H
    Contact Dermatitis; 1991 Sep; 25(3):205-6. PubMed ID: 1664309
    [No Abstract]   [Full Text] [Related]  

  • 37. Low molecular weight heparin as thromboprophylaxis throughout pregnancy in heritable thrombophilic women.
    Boda Z; László P; Pfliegler G; Tornai I; Rejtö L; Schlammadinger A
    Clin Appl Thromb Hemost; 1999 Jul; 5(3):198-9. PubMed ID: 10726010
    [No Abstract]   [Full Text] [Related]  

  • 38. A case of trichloroethylene hypersensitivity syndrome.
    Goon AT; Lee LT; Tay YK; Yosipovitch G; Ng SK; Giam YC
    Arch Dermatol; 2001 Mar; 137(3):274-6. PubMed ID: 11255324
    [No Abstract]   [Full Text] [Related]  

  • 39. [Leukocytoclastic vasculitis after injection of low-molecular-weight heparin (letter)].
    de Bats B; Rivard L; Bellemin B; Duflo F; Allaouchiche B; Chassard D
    Presse Med; 2000 Oct; 29(29):1604. PubMed ID: 11072362
    [No Abstract]   [Full Text] [Related]  

  • 40. Skin reactions due to low molecular weight heparin in pregnancy: a strategic dilemma.
    Verdonkschot AE; Vasmel WL; Middeldorp S; van der Schoot JT
    Arch Gynecol Obstet; 2005 Feb; 271(2):163-5. PubMed ID: 15112083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.